Article Versions Notes

Gál AR, Szokodi I, Vizvári Z, Győrfi N, Vereczkei A, Petykó Z, Karádi Z, Tóth A. The Pathophysiological Interrelationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease. Antioxidants. 2026; 15(6):710. https://doi.org/10.3390/antiox15060710

Gál, Adrián Róbert, István Szokodi, Zoltán Vizvári, Nina Győrfi, András Vereczkei, Zoltán Petykó, Zoltán Karádi, and Attila Tóth. 2026. "The Pathophysiological Interrelationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease" Antioxidants 15, no. 6: 710. https://doi.org/10.3390/antiox15060710

Gál, A. R., Szokodi, I., Vizvári, Z., Győrfi, N., Vereczkei, A., Petykó, Z., Karádi, Z., & Tóth, A. (2026). The Pathophysiological Interrelationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Cardiovascular Disease. Antioxidants, 15(6), 710. https://doi.org/10.3390/antiox15060710